Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|March 4, 2005

Some cardiologists cling to catheter angiography

Coronary CT angiography has proven to be a boon to radiologists and cardiologists in private practice. With a high negative predictive value, it can easily rule out coronary artery disease in patients with nondiagnostic electrocardiograms. For cardiologists in particular, CTA can help offset declining reimbursements associated with catheter procedures and nuclear medicine tests. But some cardiologists resist.

Coronary CT angiography has proven to be a boon to radiologists and cardiologists in private practice. With a high negative predictive value, it can easily rule out coronary artery disease in patients with nondiagnostic electrocardiograms. For cardiologists in particular, CTA can help offset declining reimbursements associated with catheter procedures and nuclear medicine tests. But some cardiologists resist.

"The CT coronary angiogram is demonstrating its usefulness as a noninvasive alternative to conventional catheter angiography that is capable of documenting both hard- and soft-plaque formations. With recent emphasis being placed on data surrounding the study of soft-plaque formation and its relationship to acute myocardial infarction, it seems CT angiography will become an integral tool in the prevention and treatment of coronary artery disease and acute myocardial infarction.

"Not every cardiologist is ready to roll over for coronary CTA, however. The invasive cardiologists want to know how accurate it is. Additionally, they are concerned it will take some of their income away. We see that. We tell them that cardiac CT will actually help to increase invasive procedures. Even hospitals are concerned about the potential loss of money from fewer catheter procedures. They are resistant to adopting CTA.

"Nationally, the statistics show that almost half of all cardiac cath procedures are negative, meaning they do not result in stenting or bypass surgery. If you can evaluate patients noninvasively, you're saving thousands of dollars, as well as diminishing real but low risks of mortality and morbidity."

-Dr. Steven M. Strobbe, executive physician and CEO of Florida Institute for Advanced Diagnostic Imaging in Port Richey


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.